Cagrilintide

• Strong appetite-suppressing effects through amylin receptor activation
• Slows gastric emptying, prolonging the feeling of fullness after eating
• Studied in combination with GLP-1 agonists (e.g., semaglutide) for enhanced weight loss outcomes
• May improve glycaemic control in metabolic disease research
• Long-acting profile supports once-weekly dosing in research protocols

• Preclinical and in vitro studies support amylin receptor activation and potent appetite-suppressing effects
• Long-acting acylation chemistry studied for extended dosing intervals in metabolic research protocols
• Investigated in combination with GLP-1 receptor agonists for additive metabolic effects in animal models
• Supplied for laboratory and preclinical research purposes only

Free shipping on orders over $200.

For orders under $200:

• Standard shipping: $15 flat rate
• Express shipping: $20 flat rate

We currently only ship within Australia.

All products supplied by NexusForge Research are intended strictly for professional research, laboratory, and institutional use. Product information is provided for educational and reference purposes only and should not be interpreted as medical advice.

Purchases are limited to qualified professionals, laboratories, and scientific organisations. Buyers are responsible for ensuring compliance with all applicable Australian and international laws relating to the purchase, handling, storage, use, and disposal of research materials.

Appropriate safety procedures must be followed at all times. By purchasing from NexusForge Research, the buyer agrees to use all products solely for legitimate scientific research purposes.

Product images shown on our website are for illustrative purposes only. Due to manufacturer stock availability, packaging may vary in size, design or colour from the images shown. These variations are cosmetic only and do not affect the product itself.